[go: up one dir, main page]

FI942803A0 - Ipsapirone-Proprietary Medicinal Products - Google Patents

Ipsapirone-Proprietary Medicinal Products

Info

Publication number
FI942803A0
FI942803A0 FI942803A FI942803A FI942803A0 FI 942803 A0 FI942803 A0 FI 942803A0 FI 942803 A FI942803 A FI 942803A FI 942803 A FI942803 A FI 942803A FI 942803 A0 FI942803 A0 FI 942803A0
Authority
FI
Finland
Prior art keywords
ipsapirone
medicinal products
proprietary medicinal
proprietary
products
Prior art date
Application number
FI942803A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI942803L (en
FI942803A7 (en
Inventor
Peter Serno
Wolfgang Fischer
Roland Rupp
Mark Versavel
Ulrich Tenter
Gerhard Schmidt
Guenter Schoellnhammer
Maria Ammen
Shinji Maegata
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI942803A0 publication Critical patent/FI942803A0/en
Publication of FI942803L publication Critical patent/FI942803L/en
Publication of FI942803A7 publication Critical patent/FI942803A7/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI942803A 1993-06-15 1994-06-13 Ipsapirone medicinal product FI942803A7 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4319760A DE4319760A1 (en) 1993-06-15 1993-06-15 Ipsapiron drug preparation

Publications (3)

Publication Number Publication Date
FI942803A0 true FI942803A0 (en) 1994-06-13
FI942803L FI942803L (en) 1994-12-16
FI942803A7 FI942803A7 (en) 1994-12-16

Family

ID=6490360

Family Applications (1)

Application Number Title Priority Date Filing Date
FI942803A FI942803A7 (en) 1993-06-15 1994-06-13 Ipsapirone medicinal product

Country Status (16)

Country Link
EP (1) EP0629402A1 (en)
JP (1) JPH06345649A (en)
KR (1) KR950000150A (en)
CN (1) CN1099263A (en)
AU (1) AU6345794A (en)
CA (1) CA2125620A1 (en)
CZ (1) CZ146494A3 (en)
DE (1) DE4319760A1 (en)
FI (1) FI942803A7 (en)
HU (1) HUT70759A (en)
IL (1) IL109993A0 (en)
NO (1) NO942228L (en)
NZ (1) NZ260732A (en)
PL (1) PL303822A1 (en)
SK (1) SK72494A3 (en)
ZA (1) ZA944187B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9706089D0 (en) * 1997-03-24 1997-05-14 Scherer Ltd R P Pharmaceutical composition
EP1140105B1 (en) * 1998-12-24 2003-10-22 Janssen Pharmaceutica N.V. Controlled release galantamine composition
WO2004103338A1 (en) * 2003-05-19 2004-12-02 Bioprogress Plc Adhesives and film modifying compositions
EP4062913B1 (en) * 2020-09-02 2024-05-08 Beijing Biostar Pharmaceuticals Co., Ltd. Solid oral formulation of utidelone

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0386440T3 (en) * 1989-02-11 1992-09-14 Bayer Ag Medicines with controlled release of active substance
DD297767A5 (en) * 1990-03-06 1992-01-23 Bayer Aktiengesellschaft,De MEDICINAL PRODUCTS WITH CONTROLLED ACTIVE INGREDIENTS
JPH04360826A (en) * 1991-06-07 1992-12-14 Bayer Yakuhin Kk Controlled release pharmaceutical preparation

Also Published As

Publication number Publication date
CN1099263A (en) 1995-03-01
NZ260732A (en) 1996-02-27
KR950000150A (en) 1995-01-03
IL109993A0 (en) 1994-10-07
FI942803L (en) 1994-12-16
DE4319760A1 (en) 1994-12-22
ZA944187B (en) 1995-02-08
NO942228D0 (en) 1994-06-14
JPH06345649A (en) 1994-12-20
NO942228L (en) 1994-12-16
CZ146494A3 (en) 1995-01-18
EP0629402A1 (en) 1994-12-21
FI942803A7 (en) 1994-12-16
SK72494A3 (en) 1995-04-12
PL303822A1 (en) 1995-01-09
HU9401771D0 (en) 1994-09-28
CA2125620A1 (en) 1994-12-16
HUT70759A (en) 1995-10-30
AU6345794A (en) 1994-12-22

Similar Documents

Publication Publication Date Title
FI951098L (en) Pharmaceutical packaging
FI962094A7 (en) Corneal products
FI954402L (en) New pharmaceutical product
FI956338A7 (en) Absorbent products
NO942923L (en) drugs
FI930882A0 (en) PHARMACEUTICAL FORM
FI971279A7 (en) Medicines
FI944832A7 (en) Pharmaceutical composition
NO931831D0 (en) PHARMACEUTICAL MIXTURES
ITMI932540A0 (en) PHARMACEUTICAL COMPOSITION
FI931251A0 (en) PHARMACEUTICAL FORM
DE69328718D1 (en) IMPROVED BLISTERS
DK86492D0 (en) PHARMACEUTICAL PRODUCT
NO961589D0 (en) Pharmaceutical mixtures
LV10579A (en) Pharmaceutical composition
FI942803A0 (en) Ipsapirone-Proprietary Medicinal Products
FI930922A0 (en) SUBSTITUTE PHENYLKINAZOLINE PRODUCTS
FI950737L (en) Medicines
FI934317A0 (en) PHARMACEUTICAL SAMMANSAETTNINGAR, VILKA INNEHAOLLER EJ-JONISKA YTAKTIVA AEMNEN
UA25976C2 (en) ANTI-ULTRASONIC MEDICINAL PRODUCT
DK128993D0 (en) PHARMACEUTICAL PRODUCT / -PLANTE
DK137192D0 (en) PHARMACEUTICAL PRODUCT / -PLANTE
ATE160286T1 (en) ORAL CARE PRODUCTS
NO933315D0 (en) DRUG
SE9203298D0 (en) ANTIDOPAMINE EFFECT MEDICINAL PRODUCT